Tandem Diabetes Care TNDM Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's deferred revenue?
- Tandem Diabetes Care (TNDM) reported deferred revenue of $8.95M in Q1 2026.
- How has Tandem Diabetes Care's deferred revenue changed year-over-year?
- Tandem Diabetes Care's deferred revenue decreased by 18.4% year-over-year, from $10.98M to $8.95M.
- What is the long-term trend for Tandem Diabetes Care's deferred revenue?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's deferred revenue has grown at a 9.4% compound annual growth rate (CAGR), from $6.08M to $9.53M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.